| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Medical Microbiology, Centre for Infectious Diseases, The University of Edinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK
Correspondence Ian R. Poxton i.r.poxton{at}ed.ac.uk
Received July 22, 2003
Accepted August 21, 2003
Effects on growth and toxin A production of sub-MIC concentrations of six different antibiotics were investigated in three strains of Clostridium difficile: reference strain NCTC 11223, a fully sequenced strain (630) and a locally endemic isolate (strain 338a). The antibiotics chosen for investigation were the agents used to treat C. difficile-associated disease (CDAD), i.e. vancomycin and metronidazole, and four antibiotics that are commonly involved in precipitating CDAD (amoxycillin, clindamycin, cefoxitin and ceftriaxone). Strains were cultured in sublethal concentrations of antibiotics (1/2, 1/4 and 1/8 MIC) over 104 h and growth and toxin A production were measured three times a day. Effects varied between strain and antibiotic. The most common effect on growth of the strains was to increase the initial lag period by approximately 4 h, compared with antibiotic-free controls; however, strain NCTC 11223, which has high-level clindamycin resistance (
512 µg ml-1), showed no lag whatsoever in comparison with the controls when grown in this antibiotic. The most common effect on production of toxin A was in the onset of toxin elaboration. Normally, toxins began to appear at low levels in the early stationary phase, before accumulating to high levels by the start of decline. In the presence of sub-MIC antibiotics, this onset appeared before that of the antibiotic-free controls. This effect was seen with metronidazole, amoxycillin and clindamycin, rarely with vancomycin and never with cefoxitin. These results suggest a very complex, strain-dependent relationship between the effects of growth and toxin production.
This article has been cited by other articles:
|
|
 |
|
  P. L. Hinkson, C. Dinardo, D. DeCiero, J. D. Klinger, and R. H. Barker Jr. Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2190 - 2195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Deneve, C. Delomenie, M.-C. Barc, A. Collignon, and C. Janoir Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression J. Med. Microbiol., June 1, 2008; 57(6): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gerber, C. Walch, B. Loffler, K. Tischendorf, U. Reischl, and G. Ackermann Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile J. Med. Microbiol., June 1, 2008; 57(6): 776 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Dancer The effect of antibiotics on methicillin-resistant Staphylococcus aureus J. Antimicrob. Chemother., February 1, 2008; 61(2): 246 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Freeman, S. D. Baines, K. Saxton, and M. H. Wilcox Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model J. Antimicrob. Chemother., July 1, 2007; 60(1): 83 - 91. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | J MED MICROBIOL | MICROBIOLOGY | J GEN VIROL | ALL SGM JOURNALS |
